Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 7, 2002, Pages 2077-2086

  Ciftcioglu N ^a   Miller Hjelle, M A ^a   Hjelle, J T ^a   Kajander, E O ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; AMINOGLYCOSIDE; AMPICILLIN; ANTIINFECTIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CITRATE POTASSIUM; CITRIC ACID; COTRIMOXAZOLE; FLUOROURACIL; NITROFURANTOIN; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CALCIFICATION; DILUTION; KIDNEY POLYCYSTIC DISEASE; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; URINE; BACTERIUM; DRUG EFFECT; ELECTRON MICROSCOPY; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; ULTRASTRUCTURE;

ANTI-INFECTIVE AGENTS; BACTERIA; DIPHOSPHONATES; FLUOROURACIL; KIDNEY CALCULI; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; POLYCYSTIC KIDNEY DISEASES; SUPPORT, NON-U.S. GOV'T; TETRACYCLINE; ANTI-BACTERIAL AGENTS;

EID: 0035984776     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.7.2077-2086.2002     Document Type: Article

References (83)

1. Radiolabeling and in vivo distribution of nanobacteria in rabbit
2. Mechanisms of pathologic calcification
3. Hydroxyapatite adherence as a means to concentrate bacteria
4. Extraordinary survival of nanobacteria under extreme conditions
5. Treatment of calcium urolithiasis with diphosphonate: Efficacy and hazards
6. Infection with Bartonella weissii and detection of nanobacterium antigens in a North Carolina beef herd
7. The susceptibility of a strain of Leptospira interrogans serogroup ichterohaemorrhagiae to amoxycillin, erythromycin, lincomycin, tetracycline, oxytetracycline and minocycline
8. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats
9. An infectious origin of extraskeletal calcification
10. Infectious causes of chronic inflammatory diseases and cancer
11. Changes in polyurethane calcification due to antibiotics
12. Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis
13. Nanobacteria: An infectious cause for kidney stone formation
14. Sedimentary rocks in our mouth: Dental pulp stones made by nanobacteria
15. Interaction of nanobacteria with cultured mammalian cells
16. Growth factors for nanobacteria
17. A new potential threat in antigen and antibody products: Nanobacteria
18. Extraordinary growth phases of nanobacteria isolated from mammalian blood
19. An alternative explanation of nanobacteria-induced biomineralization
20. Bisphosphonates and tetracycline: Experimental models for their evaluation in calcium-related disorders
21. Pharmacokinetic/phamacodynamic parameters: Rational for antibacterial dosing of mice and men
22. Doxycycline
23. Etidronate (HEBP) promotes osteoblast differentiation and wound closure in rat calvaria
24. Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice
25. Metronidazole susceptibility testing for Helicobacter pylori: Comparison of disk, broth, and agar dilution methods and their clinical relevance
26. Malacoplakia: A case involving epididymis and a case involving bladder complicated by calculi
27. Effects of etidronate disodium on crystallizations in synthetic urine and calcium oxalate crystal adhesion to Madin-Darby canine kidney (MDCK) cells
28. Microbiological calcification: Bone mineral and bacteria
29. Calcification by Candida albicans
30. Calcification by Escherichia coli
31. A method for assaying biofilm capacity on polyurethane-coated slides
32. Alendronate mechanism of action: Geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
33. Nanobacteria: Un modelo de neo-litogenesis experimental
34. In vitro activities of new oral β-lactams and macrolides against Campylobacter pylori
35. Optimal properties of agents used to treat acute, uncomplicated urinary tract infections
36. Treatment of pulmonary alveolar microlithiasis with a diphosphonate - Preliminary results of a case
37. Bisphosphonate therapy and vascular calcification
38. Non-invasive assessments of cardiovascular disease in patients with renal failure
39. Inhibition of calcium oxalate urolithiasis in a rat model of lithogenesis using bisphos-phonates
40. Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones
41. Antimicrobial susceptibility of 230 Helicobacter pylori strains: Importance of medium, inoculum, and incubation time
42. Development of matrix metalloproteinase inhibitors in cancer therapy
43. The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases
44. Endotoxin and nanobacteria in polycystic kidney disease
45. Nanobacteria and man
46. Nanobacteria: An alternative mechanism for pathogenic intra- and extracellular calcification and stone formation
47. Nanobacteria as extremophiles
48. Nanobacteria: Controversial pathogens in nephrolithiasis and polycystic kidney disease
49. Nanobacteria, mycoplasma and bacterial L-forms; problems for sterile filtration
50. Nanobacteria from blood, the smallest culturable autonomously replicating agent on earth
51. Comparison of staphylococci and novel bacteria-like particles from blood
52. Antibiotic corrects genetic glitch
53. β-lactams: Mode of action and mechanisms of bacterial resistance
54. Efficacy and safety of cyclical etidronate therapy in the long term treatment of osteoporosis
55. Nanobacteria. Methods for growth and identification of this recently discovered calciferous agent
56. impA, a gene coding for an inner membrane protein, influences colonial morphology of Actinobacillus actinomycetemcomitans
57. Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria
58. Bisphosphonates as anticancer drugs
59. A novel method for detection of beta-lactamase b using a chromogenic cephalosporin substrate
60. Properties of heterogeneous apatites containing magnesium, fluoride, and carbonate
61. Binding of polycationic antibiotics and polyamines to lipopolysaccharide of Pseudomonas aeruginosa
62. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption
63. Basic biological preparation techniques for TEM
64. Therapeutic approaches to bone diseases
65. Matrix metalloproteinases and their inhibition in periodontal treatment
66. Effect of tetracycline on calcium oxalate calculi: In vivo and in vitro studies
67. Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori
68. Calcification of selected strains of Streptococcus mutans and Streptococcus sanguis
69. Potassium citrate/citric acid intake improves renal function in rats with polycystic kidney disease
70. Medical treatment of ureteral calculi
71. Nanoforms: New type of protein-associated mineralization
72. Purification, amino acid sequence, and cDNA sequence of novel calcium-precipitating proteolipids involved in calcification of Coryne-bacterium matruchotii
73. Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for tat
74. Calcification of membranes isolated from Bacterionema matruchotii
75. Some pharmacokinetic aspects of doxycycline metabolism in man
76. Nanobacteria and associated 'elementary bodies' in human disease and cancer
77. Mechanisms of calcium oxalate crystal attachment to injured renal collecting duct cells
78. Morphological change in Pseudomonas aeruginosa following antibiotic treatment of experimental infection in mice and its relation to susceptibility to phagocytosis and to release of endotoxin
79. Subinhibitory antibiotic concentrations: A review of the in vitro and in vivo data